F2695 News
Most Popular F2695 Story
Forest Labs forges $75M deal for anti-depressant
Forest Laboratories has inked a deal to buy the North American rights to Pierre Fabre Medicament's experimental anti-depressant F2695 for $75 million. An undisclosed set of milestone payments are Read more...
Latest Headlines
- December 22, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
